| Year |
Citation |
Score |
| 2023 |
Lee DC, Schlienz NJ, Herrman ES, Martin EL, Leoutsakos J, Budney AJ, Smith MT, Tompkins DA, Hampson AJ, Vandrey R. Randomized controlled trial of zolpidem as a pharmacotherapy for cannabis use disorder. Journal of Substance Use and Addiction Treatment. 209180. PMID 37802317 DOI: 10.1016/j.josat.2023.209180 |
0.764 |
|
| 2023 |
Dowd AN, Zamarripa CA, Sholler DJ, Strickland JC, Goffi E, Borodovsky JT, Weerts EM, Vandrey R, Spindle TR. A cross-sectional survey on cannabis: Characterizing motives, opinions, and subjective experiences associated with the use of various oral cannabis products. Drug and Alcohol Dependence. 245: 109826. PMID 36871378 DOI: 10.1016/j.drugalcdep.2023.109826 |
0.599 |
|
| 2022 |
Kiluk BD, Kleykamp BA, Comer SD, Griffiths RR, Huhn AS, Johnson MW, Kampman KM, Pravetoni M, Preston KL, Vandrey R, Bergeria CL, Bogenschutz MP, Brown RT, Dunn KE, Dworkin RH, et al. Clinical Trial Design Challenges and Opportunities for Emerging Treatments for Opioid Use Disorder: A Review. Jama Psychiatry. PMID 36449315 DOI: 10.1001/jamapsychiatry.2022.4020 |
0.705 |
|
| 2022 |
Meier E, Rubin N, Dermody SS, Tessier KM, Hecht SS, Murphy S, Jensen J, Donny EC, al'Absi M, Drobes D, Koopmeiners J, Denlinger-Apte R, Tidey JW, Vandrey R, Thorne C, et al. Immediate Switching to Reduced Nicotine Cigarettes in a U.S.-Based Sample: The Impact on Cannabis Use and Related Variables at 20 Weeks. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 36198098 DOI: 10.1093/ntr/ntac231 |
0.625 |
|
| 2022 |
Garcia-Romeu A, Elmore J, Mayhugh RE, Schlienz NJ, Martin EL, Strickland JC, Bonn-Miller M, Jackson H, Vandrey R. Online survey of medicinal cannabis users: Qualitative analysis of patient-level data. Frontiers in Pharmacology. 13: 965535. PMID 36147312 DOI: 10.3389/fphar.2022.965535 |
0.716 |
|
| 2022 |
Klemperer EM, Luo X, Jensen J, al'Absi M, Cinciripini PM, Robinson JD, Drobes DJ, McClernon J, Strasser AA, Strayer LG, Vandrey R, Benowitz NL, Donny EC, Hatsukami DK. Smoking abstinence and cessation-related outcomes one month after an immediate versus gradual reduction in nicotine content of cigarettes. Preventive Medicine. 107175. PMID 35870575 DOI: 10.1016/j.ypmed.2022.107175 |
0.621 |
|
| 2022 |
Lapham GT, Matson TE, Carrell DS, Bobb JF, Luce C, Oliver MM, Ghitza UE, Hsu C, Browne KC, Binswanger IA, Campbell CI, Saxon AJ, Vandrey R, Schauer GL, Pacula RL, et al. Comparison of Medical Cannabis Use Reported on a Confidential Survey vs Documented in the Electronic Health Record Among Primary Care Patients. Jama Network Open. 5: e2211677. PMID 35604691 DOI: 10.1001/jamanetworkopen.2022.11677 |
0.678 |
|
| 2021 |
Martin EL, Strickland JC, Schlienz NJ, Munson J, Jackson H, Bonn-Miller MO, Vandrey R. Antidepressant and Anxiolytic Effects of Medicinal Cannabis Use in an Observational Trial. Frontiers in Psychiatry. 12: 729800. PMID 34566726 DOI: 10.3389/fpsyt.2021.729800 |
0.703 |
|
| 2021 |
Strickland JC, Jackson H, Schlienz NJ, Salpekar JA, Martin EL, Munson J, Bonn-Miller MO, Vandrey R. Cross-sectional and longitudinal evaluation of cannabidiol (CBD) product use and health among people with epilepsy. Epilepsy & Behavior : E&B. 122: 108205. PMID 34311183 DOI: 10.1016/j.yebeh.2021.108205 |
0.695 |
|
| 2021 |
Sholler DJ, Moran MB, Dolan SB, Borodovsky JT, Alonso F, Vandrey R, Spindle TR. Use patterns, beliefs, experiences, and behavioral economic demand of indica and sativa cannabis: A cross-sectional survey of cannabis users. Experimental and Clinical Psychopharmacology. PMID 33856822 DOI: 10.1037/pha0000462 |
0.642 |
|
| 2020 |
Schlienz NJ, Scalsky R, Martin EL, Jackson H, Munson J, Strickland JC, Bonn-Miller MO, Loflin M, Vandrey R. A Cross-Sectional and Prospective Comparison of Medicinal Cannabis Users and Controls on Self-Reported Health. Cannabis and Cannabinoid Research. PMID 33998852 DOI: 10.1089/can.2019.0096 |
0.705 |
|
| 2020 |
Dermody SS, Tessier KM, Meier E, al'Absi M, Denlinger-Apte RL, Drobes DJ, Jensen J, Koopmeiners JS, Pacek LR, Tidey JW, Vandrey R, Donny E, Hatsukami D. An Evaluation of Potential Unintended Consequences of a Nicotine Product Standard: A Focus on Drinking History and Outcomes. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 33220047 DOI: 10.1093/ntr/ntaa236 |
0.746 |
|
| 2020 |
Suraev AS, Marshall NS, Vandrey R, McCartney D, Benson MJ, McGregor IS, Grunstein RR, Hoyos CM. Cannabinoid therapies in the management of sleep disorders: A systematic review of preclinical and clinical studies. Sleep Medicine Reviews. 53: 101339. PMID 32603954 DOI: 10.1016/J.Smrv.2020.101339 |
0.314 |
|
| 2020 |
Spindle TR, Cone EJ, Herrmann ES, Mitchell JM, Flegel R, LoDico C, Bigelow GE, Vandrey R. Pharmacokinetics of Cannabis Brownies: A Controlled Examination of Δ9-Tetrahydrocannabinol and Metabolites in Blood and Oral Fluid of Healthy Adult Males and Females. Journal of Analytical Toxicology. PMID 32591782 DOI: 10.1093/Jat/Bkaa067 |
0.325 |
|
| 2020 |
Suraev A, Grunstein RR, Marshall NS, D'Rozario AL, Gordon CJ, Bartlett DJ, Wong K, Yee BJ, Vandrey R, Irwin C, Arnold JC, McGregor IS, Hoyos CM. Cannabidiol (CBD) and Δ-tetrahydrocannabinol (THC) for chronic insomnia disorder ('CANSLEEP' trial): protocol for a randomised, placebo-controlled, double-blinded, proof-of-concept trial. Bmj Open. 10: e034421. PMID 32430450 DOI: 10.1136/Bmjopen-2019-034421 |
0.353 |
|
| 2020 |
Loflin MJE, Kiluk BD, Huestis MA, Aklin WM, Budney AJ, Carroll KM, D'Souza DC, Dworkin RH, Gray KM, Hasin DS, Lee DC, Le Foll B, Levin FR, Lile JA, Mason BJ, ... ... Vandrey R, et al. The state of clinical outcome assessments for cannabis use disorder clinical trials: A review and research agenda. Drug and Alcohol Dependence. 107993. PMID 32360455 DOI: 10.1016/J.Drugalcdep.2020.107993 |
0.576 |
|
| 2020 |
Strickland JC, Lee DC, Vandrey R, Johnson MW. A systematic review and meta-analysis of delay discounting and cannabis use. Experimental and Clinical Psychopharmacology. PMID 32309968 DOI: 10.1037/Pha0000378 |
0.325 |
|
| 2020 |
Schlienz NJ, Spindle TR, Cone EJ, Herrmann ES, Bigelow GE, Mitchell JM, Flegel R, LoDico C, Vandrey R. Pharmacodynamic dose effects of oral cannabis ingestion in healthy adults who infrequently use cannabis. Drug and Alcohol Dependence. 211: 107969. PMID 32298998 DOI: 10.1016/J.Drugalcdep.2020.107969 |
0.755 |
|
| 2020 |
Spindle TR, Cone EJ, Goffi E, Weerts EM, Mitchell JM, Winecker RE, Bigelow GE, Flegel RR, Vandrey R. Pharmacodynamic effects of vaporized and oral cannabidiol (CBD) and vaporized CBD-dominant cannabis in infrequent cannabis users. Drug and Alcohol Dependence. 107937. PMID 32247649 DOI: 10.1016/J.Drugalcdep.2020.107937 |
0.367 |
|
| 2020 |
Carroll DM, Murphy SE, Benowitz NL, Strasser AA, Kotlyar M, Carmella SG, McClernon FJ, Pacek LR, Dermody SS, Vandrey RG, Donny EC, Hatsukami DK. Relationships between the nicotine metabolite ratio and a panel of exposure and effect biomarkers: findings from two studies of U.S. commercial cigarette smokers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 32051195 DOI: 10.1158/1055-9965.Epi-19-0644 |
0.787 |
|
| 2020 |
Rosenberg P, Forester B, Agronin M, Kasckow J, Amjad H, Burhanullah H, Vandrey R, Outen J, Skurla M, May R, Isesalaya M. TRIAL OF DRONABINOL ADJUNCTIVE TREATMENT OF AGITATION IN ALZHEIMER'S DISEASE (AD) (THC-AD) The American Journal of Geriatric Psychiatry. 28: S121-S122. DOI: 10.1016/J.Jagp.2020.01.150 |
0.323 |
|
| 2019 |
Wilhelm J, Abudayyeh H, Perreras L, Taylor R, Peters EN, Vandrey R, Hedeker D, Mermelstein R, Cohn A. Measuring the temporal association between cannabis and tobacco use among Co-using young adults using ecological momentary assessment. Addictive Behaviors. 104: 106250. PMID 31918167 DOI: 10.1016/J.Addbeh.2019.106250 |
0.348 |
|
| 2019 |
Smith TT, Donny EC, Luo X, Allen AM, Carroll DM, Denlinger-Apte RL, Dermody SS, Koopmeiners JS, McClernon FJ, Pacek LR, Vandrey R, Hatsukami DK. The Impact of Gradual and Immediate Nicotine Reduction on Subjective Cigarette Ratings. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 21: S73-S80. PMID 31867651 DOI: 10.1093/Ntr/Ntz158 |
0.803 |
|
| 2019 |
Denlinger-Apte RL, Kotlyar M, Koopmeiners JS, Tidey JW, Luo X, Benowitz NL, Jensen JA, Ikuemonisan JO, Pacek LR, Smith TT, Vandrey R, Donny EC, Hatsukami DK. Effects of Very Low Nicotine Content Cigarettes on Smoking Behavior and Biomarkers of Exposure in Menthol and Non-menthol Smokers. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 21: S63-S72. PMID 31867637 DOI: 10.1093/Ntr/Ntz160 |
0.759 |
|
| 2019 |
Meier E, Vandrey R, Rubin N, Pacek LR, Jensen JA, Donny EC, Hecht SS, Carmella SG, Murphy SE, Luo X, Stepanov I, Ikuemonisan J, Severson H, al'Absi M, Hatsukami DK. Cigarette Smokers vs. Co-users of Cannabis and Cigarettes: Exposure to Toxicants. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 31616939 DOI: 10.1093/Ntr/Ntz199 |
0.752 |
|
| 2019 |
Hatsukami DK, Luo X, Heskin AK, Tang MK, Carmella SG, Jensen J, Robinson JD, Vandrey R, Drobes DJ, Strasser AA, al'Absi M, Leischow S, Cinciripini PM, Koopmeiners J, Ikuemonisan J, et al. Effects of immediate versus gradual nicotine reduction in cigarettes on biomarkers of biological effects. Addiction (Abingdon, England). PMID 31140663 DOI: 10.1111/Add.14695 |
0.617 |
|
| 2019 |
Spindle TR, Cone EJ, Schlienz NJ, Mitchell JM, Bigelow GE, Flegel R, Hayes E, Vandrey R. Urinary Excretion Profile of 11-Nor-9-Carboxy-Δ9-Tetrahydrocannabinol (THCCOOH) Following Smoked and Vaporized Cannabis Administration in Infrequent Cannabis Users. Journal of Analytical Toxicology. PMID 31095692 DOI: 10.1093/Jat/Bkz038 |
0.761 |
|
| 2019 |
Carmella SG, Heskin AK, Tang MK, Jensen J, Luo X, Le CT, Murphy SE, Benowitz NL, McClernon FJ, Vandrey R, Allen SS, Denlinger-Apte R, Cinciripini PM, Strasser AA, al'Absi M, et al. Longitudinal stability in cigarette smokers of urinary eicosanoid biomarkers of oxidative damage and inflammation. Plos One. 14: e0215853. PMID 31022220 DOI: 10.1371/Journal.Pone.0215853 |
0.704 |
|
| 2019 |
Spindle TR, Cone EJ, Schlienz NJ, Mitchell JM, Bigelow GE, Flegel R, Hayes E, Vandrey R. Acute Pharmacokinetic Profile of Smoked and Vaporized Cannabis in Human Blood and Oral Fluid. Journal of Analytical Toxicology. PMID 30615181 DOI: 10.1093/Jat/Bky104 |
0.754 |
|
| 2019 |
Chen M, Carmella SG, Sipe C, Jensen J, Luo X, Le CT, Murphy SE, Benowitz NL, McClernon FJ, Vandrey R, Allen SS, Denlinger-Apte R, Cinciripini PM, Strasser AA, al'Absi M, et al. Longitudinal stability in cigarette smokers of urinary biomarkers of exposure to the toxicants acrylonitrile and acrolein. Plos One. 14: e0210104. PMID 30608961 DOI: 10.1371/Journal.Pone.0210104 |
0.734 |
|
| 2018 |
Spindle TR, Cone EJ, Schlienz NJ, Mitchell JM, Bigelow GE, Flegel R, Hayes E, Vandrey R. Acute Effects of Smoked and Vaporized Cannabis in Healthy Adults Who Infrequently Use Cannabis: A Crossover Trial. Jama Network Open. 1: e184841. PMID 30646391 DOI: 10.1001/jamanetworkopen.2018.4841 |
0.728 |
|
| 2018 |
Lee DC, Schlienz NJ, Peters EN, Dworkin RH, Turk DC, Strain EC, Vandrey R. Systematic review of outcome domains and measures used in psychosocial and pharmacological treatment trials for cannabis use disorder. Drug and Alcohol Dependence. 194: 500-517. PMID 30530238 DOI: 10.1016/J.Drugalcdep.2018.10.020 |
0.723 |
|
| 2018 |
Hatsukami DK, Luo X, Jensen JA, al'Absi M, Allen SS, Carmella SG, Chen M, Cinciripini PM, Denlinger-Apte R, Drobes DJ, Koopmeiners JS, Lane T, Le CT, Leischow S, Luo K, ... ... Vandrey R, et al. Effect of Immediate vs Gradual Reduction in Nicotine Content of Cigarettes on Biomarkers of Smoke Exposure: A Randomized Clinical Trial. Jama. 320: 880-891. PMID 30193275 DOI: 10.1001/Jama.2018.11473 |
0.717 |
|
| 2018 |
Schlienz NJ, Lee DC, Stitzer ML, Vandrey R. The effect of high-dose dronabinol (oral THC) maintenance on cannabis self-administration. Drug and Alcohol Dependence. 187: 254-260. PMID 29689485 DOI: 10.1016/J.Drugalcdep.2018.02.022 |
0.811 |
|
| 2018 |
Barrett FS, Schlienz NJ, Lembeck N, Waqas M, Vandrey R. "Hallucinations" Following Acute Cannabis Dosing: A Case Report and Comparison to Other Hallucinogenic Drugs. Cannabis and Cannabinoid Research. 3: 85-93. PMID 29682608 DOI: 10.1089/can.2017.0052 |
0.696 |
|
| 2018 |
Dermody SS, McClernon FJ, Benowitz N, Luo X, Tidey JW, Smith TT, Vandrey R, Hatsukami D, Donny EC. Effects of reduced nicotine content cigarettes on individual withdrawal symptoms over time and during abstinence. Experimental and Clinical Psychopharmacology. PMID 29504780 DOI: 10.1037/Pha0000179 |
0.74 |
|
| 2018 |
Martin EL, Schlienz NJ, Herrmann ES, Budney AJ, Lee DC, Hampson A, Smith M, Leoutsakos JS, Stitzer ML, Vandrey RG. 1000 Targeting Sleep in Adults Seeking Treatment for Cannabis Use Disorder Sleep. 41: A370-A370. DOI: 10.1093/Sleep/Zsy061.999 |
0.772 |
|
| 2018 |
Vandrey R, Budney A, Herrmann E, Schlienz N, Hampson A, Smith M, Stitzer M. 166. Targeting Sleep Disturbance in the Treatment of Cannabis Use Disorders Biological Psychiatry. 83: S67. DOI: 10.1016/J.Biopsych.2018.02.184 |
0.768 |
|
| 2017 |
Schlienz NJ, Cone EJ, Herrmann ES, Lembeck NA, Mitchell JM, Bigelow GE, Flegel R, LoDico CP, Hayes ED, Vandrey R. Pharmacokinetic Characterization of 11-nor-9-carboxy-Δ9-tetrahydrocannabinol in Urine Following Acute Oral Cannabis Ingestion in Healthy Adults. Journal of Analytical Toxicology. PMID 29300962 DOI: 10.1093/Jat/Bkx102 |
0.73 |
|
| 2017 |
Schlienz NJ, Budney AJ, Lee DC, Vandrey R. Cannabis Withdrawal: A Review of Neurobiological Mechanisms and Sex Differences. Current Addiction Reports. 4: 75-81. PMID 29057200 DOI: 10.1007/S40429-017-0143-1 |
0.749 |
|
| 2017 |
Pacek LR, Herrmann ES, Smith MT, Vandrey R. Sleep continuity, architecture and quality among treatment-seeking cannabis users: An in-home, unattended polysomnographic study. Experimental and Clinical Psychopharmacology. 25: 295-302. PMID 28782982 DOI: 10.1037/Pha0000126 |
0.588 |
|
| 2017 |
Pacek LR, Joseph McClernon F, Denlinger-Apte RL, Mercincavage M, Strasser AA, Dermody SS, Vandrey R, Smith TT, Nardone N, Hatsukami DK, Koopmeiners JS, Kozink RV, Donny EC. Perceived nicotine content of reduced nicotine content cigarettes is a correlate of perceived health risks. Tobacco Control. PMID 28735272 DOI: 10.1136/Tobaccocontrol-2017-053689 |
0.742 |
|
| 2017 |
Gray KM, Sonne SC, McClure EA, Ghitza UE, Matthews AG, McRae-Clark AL, Carroll KM, Potter JS, Wiest K, Mooney LJ, Hasson A, Walsh SL, Lofwall MR, Babalonis S, Lindblad RW, ... ... Vandrey RG, et al. A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults. Drug and Alcohol Dependence. 177: 249-257. PMID 28623823 DOI: 10.1016/J.Drugalcdep.2017.04.020 |
0.7 |
|
| 2017 |
Vandrey R, Herrmann ES, Mitchell JM, Bigelow GE, Flegel R, LoDico C, Cone EJ. Pharmacokinetic Profile of Oral Cannabis in Humans: Blood and Oral Fluid Disposition and Relation to Pharmacodynamic Outcomes. Journal of Analytical Toxicology. 1-17. PMID 28158482 DOI: 10.1093/Jat/Bkx012 |
0.315 |
|
| 2017 |
Pacek L, McClernon FJ, Denlinger R, Mercincavage M, Strasser A, Vandrey R, Nardone N, Hatsukami D, Donny E. Perceived nicotine content and its association with perceived disease risks of spectrum research cigarettes Drug and Alcohol Dependence. 171: e157. DOI: 10.1016/J.Drugalcdep.2016.08.432 |
0.769 |
|
| 2016 |
Rupprecht LE, Koopmeiners JS, Dermody SS, Oliver JA, al'Absi M, Benowitz NL, Denlinger-Apte R, Drobes DJ, Hatsukami D, McClernon FJ, Pacek LR, Smith TT, Sved AF, Tidey J, Vandrey R, et al. Reducing nicotine exposure results in weight gain in smokers randomised to very low nicotine content cigarettes. Tobacco Control. PMID 27856940 DOI: 10.1136/Tobaccocontrol-2016-053301 |
0.784 |
|
| 2016 |
Higgins ST, Heil SH, Sigmon SC, Tidey JW, Gaalema DE, Stitzer ML, Durand H, Bunn JY, Priest JS, Arger CA, Miller ME, Bergeria CL, Davis DR, Streck JM, Zvorsky I, ... ... Vandrey R, et al. Response to varying the nicotine content of cigarettes in vulnerable populations: an initial experimental examination of acute effects. Psychopharmacology. PMID 27714427 DOI: 10.1007/S00213-016-4438-Z |
0.765 |
|
| 2016 |
Tidey JW, Pacek LR, Koopmeiners JS, Vandrey R, Nardone N, Drobes DJ, Benowitz NL, Dermody SS, Lemieux A, Denlinger RL, Cassidy R, al'Absi M, Hatsukami DK, Donny EC. Effects of 6-Week Use of Reduced-Nicotine Content Cigarettes in Smokers With and Without Elevated Depressive Symptoms. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 27613885 DOI: 10.1093/Ntr/Ntw199 |
0.749 |
|
| 2016 |
Pacek LR, Vandrey R, Dermody SS, Denlinger-Apte RL, Lemieux A, Tidey JW, McClernon FJ, Bangdiwala AS, Drobes DJ, al'Absi M, Strasser AA, Koopmeiners JS, Hatsukami DK, Donny EC. Evaluation of a reduced nicotine product standard: Moderating effects of and impact on cannabis use. Drug and Alcohol Dependence. PMID 27590743 DOI: 10.1016/J.Drugalcdep.2016.08.620 |
0.792 |
|
| 2016 |
Schuster RM, Hanly A, Gilman J, Budney A, Vandrey R, Evins AE. A contingency management method for 30-days abstinence in non-treatment seeking young adult cannabis users. Drug and Alcohol Dependence. PMID 27590742 DOI: 10.1016/J.Drugalcdep.2016.08.622 |
0.591 |
|
| 2016 |
Nardone N, Donny EC, Hatsukami DK, Koopmeiners JS, Murphy SE, Strasser AA, Tidey JW, Vandrey R, Benowitz NL. Estimations and Predictors of Non-Compliance in Switchers to Reduced Nicotine Content Cigarettes. Addiction (Abingdon, England). PMID 27367436 DOI: 10.1111/Add.13519 |
0.646 |
|
| 2016 |
Dermody SS, Tidey JW, Denlinger RL, Pacek LR, al'Absi M, Drobes DJ, Hatsukami DK, Vandrey R, Donny EC. The Impact of Smoking Very Low Nicotine Content Cigarettes on Alcohol Use. Alcoholism, Clinical and Experimental Research. PMID 26916879 DOI: 10.1111/Acer.12980 |
0.759 |
|
| 2015 |
Dunn K, Marcus T, Kim C, Schroeder JR, Vandrey R, Umbricht A. Zonisamide Reduces Withdrawal Symptoms But Does Not Enhance Varenicline-induced Smoking Cessation. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 26476459 DOI: 10.1093/Ntr/Ntv236 |
0.455 |
|
| 2015 |
Herrmann ES, Weerts EM, Vandrey R. Sex Differences in Cannabis Withdrawal Symptoms Among Treatment-Seeking Cannabis Users. Experimental and Clinical Psychopharmacology. PMID 26461168 DOI: 10.1037/Pha0000053 |
0.316 |
|
| 2015 |
Donny EC, Denlinger RL, Tidey JW, Koopmeiners JS, Benowitz NL, Vandrey RG, al'Absi M, Carmella SG, Cinciripini PM, Dermody SS, Drobes DJ, Hecht SS, Jensen J, Lane T, Le CT, et al. Randomized Trial of Reduced-Nicotine Standards for Cigarettes. The New England Journal of Medicine. 373: 1340-1349. PMID 26422724 DOI: 10.1056/Nejmsa1502403 |
0.777 |
|
| 2015 |
Lee D, Bergamaschi MM, Milman G, Barnes AJ, Queiroz RH, Vandrey R, Huestis MA. Plasma Cannabinoid Pharmacokinetics After Controlled Smoking and Ad libitum Cannabis Smoking in Chronic Frequent Users. Journal of Analytical Toxicology. 39: 580-7. PMID 26378131 DOI: 10.1093/Jat/Bkv082 |
0.428 |
|
| 2015 |
Belendiuk KA, Babson KA, Vandrey R, Bonn-Miller MO. Cannabis species and cannabinoid concentration preference among sleep-disturbed medicinal cannabis users. Addictive Behaviors. 50: 178-81. PMID 26151582 DOI: 10.1016/J.Addbeh.2015.06.032 |
0.319 |
|
| 2015 |
Cone EJ, Bigelow GE, Herrmann ES, Mitchell JM, LoDico C, Flegel R, Vandrey R. Nonsmoker Exposure to Secondhand Cannabis Smoke. III. Oral Fluid and Blood Drug Concentrations and Corresponding Subjective Effects. Journal of Analytical Toxicology. PMID 26139312 DOI: 10.1093/Jat/Bkv070 |
0.428 |
|
| 2015 |
Herrmann ES, Cone EJ, Mitchell JM, Bigelow GE, LoDico C, Flegel R, Vandrey R. Non-smoker exposure to secondhand cannabis smoke II: Effect of room ventilation on the physiological, subjective, and behavioral/cognitive effects. Drug and Alcohol Dependence. 151: 194-202. PMID 25957157 DOI: 10.1016/J.Drugalcdep.2015.03.019 |
0.413 |
|
| 2015 |
Cochran G, Stitzer M, Campbell AN, Hu MC, Vandrey R, Nunes EV. Web-based treatment for substance use disorders: differential effects by primary substance. Addictive Behaviors. 45: 191-4. PMID 25697725 DOI: 10.1016/j.addbeh.2015.02.002 |
0.601 |
|
| 2015 |
McClure EA, Campbell AN, Pavlicova M, Hu M, Winhusen T, Vandrey RG, Ruglass LM, Covey LS, Stitzer ML, Kyle TL, Nunes EV. Cigarette Smoking During Substance Use Disorder Treatment: Secondary Outcomes from a National Drug Abuse Treatment Clinical Trials Network study. Journal of Substance Abuse Treatment. 53: 39-46. PMID 25595301 DOI: 10.1016/J.Jsat.2014.12.007 |
0.815 |
|
| 2015 |
Kleykamp BA, Vandrey RG, Bigelow GE, Strain EC, Mintzer MZ. Effects of methadone plus alcohol on cognitive performance in methadone-maintained volunteers. The American Journal of Drug and Alcohol Abuse. 41: 251-6. PMID 25584897 DOI: 10.3109/00952990.2014.987348 |
0.75 |
|
| 2015 |
Cone EJ, Bigelow GE, Herrmann ES, Mitchell JM, LoDico C, Flegel R, Vandrey R. Non-smoker exposure to secondhand cannabis smoke. I. Urine screening and confirmation results. Journal of Analytical Toxicology. 39: 1-12. PMID 25326203 DOI: 10.1093/Jat/Bku116 |
0.426 |
|
| 2015 |
Lee D, Vandrey R, Mendu DR, Murray JA, Barnes AJ, Huestis MA. Oral fluid cannabinoids in chronic frequent cannabis smokers during ad libitum cannabis smoking. Drug Testing and Analysis. 7: 494-501. PMID 25220020 DOI: 10.1002/Dta.1718 |
0.418 |
|
| 2015 |
Pacek LR, Vandrey R, Tidey JW, Drobes DJ, Koopmeiners J, Umbricht A, Hatsukami D, Donny E. The impact of nicotine dose assignment on affect and depression during extended exposure to experimental Spectrum cigarettes: Findings from CENIC Project 1 Study 1 Drug and Alcohol Dependence. 156: e168-e169. DOI: 10.1016/J.Drugalcdep.2015.07.458 |
0.724 |
|
| 2015 |
Herrmann ES, Weerts E, Vandrey R. Gender differences in cannabis withdrawal symptoms among treatment-seeking cannabis users Drug and Alcohol Dependence. 156: e95. DOI: 10.1016/J.Drugalcdep.2015.07.1175 |
0.325 |
|
| 2015 |
Vandrey R, Budney AJ, Smith M, Herrmann E, Hampson A, Stitzer M. A pilot study of zolpidem pharmacotherapy in the treatment of cannabis use disorders Drug and Alcohol Dependence. 146: e10. DOI: 10.1016/J.Drugalcdep.2014.09.708 |
0.714 |
|
| 2015 |
Disney E, Stoller KB, Vandrey R. Synthetic cannabinoid use and awareness in a drug abuse treatment clinic Drug and Alcohol Dependence. 146: e267-e268. DOI: 10.1016/J.Drugalcdep.2014.09.193 |
0.319 |
|
| 2014 |
McClure EA, Sonne SC, Winhusen T, Carroll KM, Ghitza UE, McRae-Clark AL, Matthews AG, Sharma G, Van Veldhuisen P, Vandrey RG, Levin FR, Weiss RD, Lindblad R, Allen C, Mooney LJ, et al. Achieving cannabis cessation -- evaluating N-acetylcysteine treatment (ACCENT): design and implementation of a multi-site, randomized controlled study in the National Institute on Drug Abuse Clinical Trials Network. Contemporary Clinical Trials. 39: 211-23. PMID 25179587 DOI: 10.1016/J.Cct.2014.08.011 |
0.729 |
|
| 2014 |
Pacek LR, Vandrey R. Cannabis use history and characteristics of quit attempts: a comparison study of treatment-seeking and non-treatment-seeking cannabis users. Experimental and Clinical Psychopharmacology. 22: 517-23. PMID 25150537 DOI: 10.1037/A0037791 |
0.662 |
|
| 2014 |
Rass O, Kleykamp BA, Vandrey RG, Bigelow GE, Leoutsakos JM, Stitzer ML, Strain EC, Copersino ML, Mintzer MZ. Cognitive performance in methadone maintenance patients: effects of time relative to dosing and maintenance dose level. Experimental and Clinical Psychopharmacology. 22: 248-56. PMID 24548244 DOI: 10.1037/A0035712 |
0.755 |
|
| 2014 |
Milman G, Bergamaschi MM, Lee D, Mendu DR, Barnes AJ, Vandrey R, Huestis MA. Plasma cannabinoid concentrations during dronabinol pharmacotherapy for cannabis dependence Therapeutic Drug Monitoring. 36: 218-224. PMID 24067260 DOI: 10.1097/Ftd.0B013E3182A5C446 |
0.416 |
|
| 2014 |
Pacek LR, Vandrey R. Cannabis use history and characteristics of quit attempts: A comparison study of treatment-seeking and non-treatment-seeking cannabis users Experimental and Clinical Psychopharmacology. 22: 517-523. DOI: 10.1037/a0037791 |
0.617 |
|
| 2014 |
Vandrey R, Stitzer M. Effect of dronabinol (oral THC) maintenance on cannabis self-administration Drug and Alcohol Dependence. 140: e232. DOI: 10.1016/J.Drugalcdep.2014.02.643 |
0.612 |
|
| 2014 |
Khalil M, Stitzer M, Vandrey R. Sleep quality among cannabis users seeking treatment Drug and Alcohol Dependence. 140: e102-e103. DOI: 10.1016/J.Drugalcdep.2014.02.296 |
0.617 |
|
| 2013 |
Lee D, Vandrey R, Mendu DR, Anizan S, Milman G, Murray JA, Barnes AJ, Huestis MA. Oral fluid cannabinoids in chronic cannabis smokers during oral δ9-tetrahydrocannabinol therapy and smoked cannabis challenge. Clinical Chemistry. 59: 1770-9. PMID 23938457 DOI: 10.1373/Clinchem.2013.207316 |
0.452 |
|
| 2013 |
Lee D, Vandrey R, Milman G, Bergamaschi M, Mendu DR, Murray JA, Barnes AJ, Huestis MA. Oral fluid/plasma cannabinoid ratios following controlled oral THC and smoked cannabis administration. Analytical and Bioanalytical Chemistry. 405: 7269-79. PMID 23831756 DOI: 10.1007/S00216-013-7159-8 |
0.427 |
|
| 2013 |
Vandrey R, Stitzer ML, Mintzer MZ, Huestis MA, Murray JA, Lee D. The dose effects of short-term dronabinol (oral THC) maintenance in daily cannabis users. Drug and Alcohol Dependence. 128: 64-70. PMID 22921474 DOI: 10.1016/J.Drugalcdep.2012.08.001 |
0.791 |
|
| 2013 |
McClure EA, Vandrey RG, Johnson MW, Stitzer ML. Effects of varenicline on abstinence and smoking reward following a programmed lapse. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 15: 139-48. PMID 22573730 DOI: 10.1093/Ntr/Nts101 |
0.808 |
|
| 2012 |
Henry PK, Umbricht A, Kleykamp BA, Vandrey R, Strain EC, Bigelow GE, Mintzer MZ. Comparison of cognitive performance in methadone maintenance patients with and without current cocaine dependence. Drug and Alcohol Dependence. 124: 167-71. PMID 22266090 DOI: 10.1016/J.Drugalcdep.2011.12.009 |
0.756 |
|
| 2012 |
McClure EA, Stitzer ML, Vandrey R. Characterizing smoking topography of cannabis in heavy users. Psychopharmacology. 220: 309-18. PMID 21922170 DOI: 10.1007/S00213-011-2480-4 |
0.823 |
|
| 2012 |
Vandrey R, Dunn KE, Fry JA, Girling ER. A survey study to characterize use of Spice products (synthetic cannabinoids) Drug and Alcohol Dependence. 120: 238-241. PMID 21835562 DOI: 10.1016/J.Drugalcdep.2011.07.011 |
0.364 |
|
| 2011 |
Vandrey R, Stitzer ML, Acquavita SP, Quinn-Stabile P. Pay-for-performance in a community substance abuse clinic. Journal of Substance Abuse Treatment. 41: 193-200. PMID 21489739 DOI: 10.1016/J.Jsat.2011.03.001 |
0.579 |
|
| 2011 |
Vandrey R, Umbricht A, Strain EC. Increased blood pressure after abrupt cessation of daily cannabis use Journal of Addiction Medicine. 5: 16-20. PMID 21359104 DOI: 10.1097/Adm.0B013E3181D2B309 |
0.399 |
|
| 2011 |
Vandrey R, Smith MT, McCann UD, Budney AJ, Curran EM. Sleep disturbance and the effects of extended-release zolpidem during cannabis withdrawal. Drug and Alcohol Dependence. 117: 38-44. PMID 21296508 DOI: 10.1016/J.Drugalcdep.2011.01.003 |
0.562 |
|
| 2010 |
Budney AJ, Vandrey RG, Stanger C. Pharmacological and psychosocial interventions for cannabis use disorders | Intervenções farmacológica e psicossocial para os distúrbios de uso da cannabis Revista Brasileira De Psiquiatria. 32: S46-S55. PMID 20512270 |
0.545 |
|
| 2010 |
Budney AJ, Vandrey RG, Stanger C. Intervenções farmacológica e psicossocial para os distúrbios por uso da cannabis Revista Brasileira De Psiquiatria. 32: 546-555. DOI: 10.1590/S1516-44462010000500008 |
0.437 |
|
| 2008 |
Budney AJ, Vandrey RG, Hughes JR, Thostenson JD, Bursac Z. Comparison of cannabis and tobacco withdrawal: severity and contribution to relapse. Journal of Substance Abuse Treatment. 35: 362-8. PMID 18342479 DOI: 10.1016/j.jsat.2008.01.002 |
0.586 |
|
| 2008 |
Stitzer ML, Vandrey R. Contingency management: utility in the treatment of drug abuse disorders. Clinical Pharmacology and Therapeutics. 83: 644-7. PMID 18305456 DOI: 10.1038/sj.clpt.6100508 |
0.599 |
|
| 2008 |
Vandrey RG, Budney AJ, Hughes JR, Liguori A. A within-subject comparison of withdrawal symptoms during abstinence from cannabis, tobacco, and both substances. Drug and Alcohol Dependence. 92: 48-54. PMID 17643868 DOI: 10.1016/J.Drugalcdep.2007.06.010 |
0.618 |
|
| 2007 |
Stitzer ML, Peirce J, Petry NM, Kirby K, Roll J, Krasnansky J, Cohen A, Blaine J, Vandrey R, Kolodner K, Li R. Abstinence-based incentives in methadone maintenance: interaction with intake stimulant test results. Experimental and Clinical Psychopharmacology. 15: 344-50. PMID 17696681 DOI: 10.1037/1064-1297.15.4.344 |
0.623 |
|
| 2007 |
Vandrey R, Bigelow GE, Stitzer ML. Contingency management in cocaine abusers: a dose-effect comparison of goods-based versus cash-based incentives. Experimental and Clinical Psychopharmacology. 15: 338-43. PMID 17696680 DOI: 10.1037/1064-1297.15.4.338 |
0.614 |
|
| 2007 |
Budney AJ, Vandrey RG, Hughes JR, Moore BA, Bahrenburg B. Oral delta-9-tetrahydrocannabinol suppresses cannabis withdrawal symptoms. Drug and Alcohol Dependence. 86: 22-9. PMID 16769180 DOI: 10.1016/j.drugalcdep.2006.04.014 |
0.6 |
|
| 2005 |
Vandrey R, Budney AJ, Kamon JL, Stanger C. Cannabis withdrawal in adolescent treatment seekers Drug and Alcohol Dependence. 78: 205-210. PMID 15845324 DOI: 10.1016/j.drugalcdep.2004.11.001 |
0.55 |
|
| 2005 |
Vandrey RG, Budney AJ, Moore BA, Hughes JR. A cross-study comparison of cannabis and tobacco withdrawal. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 14: 54-63. PMID 15804877 DOI: 10.1080/10550490590899853 |
0.552 |
|
| 2004 |
Budney AJ, Hughes JR, Moore BA, Vandrey R. Review of the validity and significance of cannabis withdrawal syndrome. The American Journal of Psychiatry. 161: 1967-77. PMID 15514394 DOI: 10.1176/Appi.Ajp.161.11.1967 |
0.554 |
|
| 2003 |
Budney AJ, Moore BA, Vandrey RG, Hughes JR. The time course and significance of cannabis withdrawal. Journal of Abnormal Psychology. 112: 393-402. PMID 12943018 DOI: 10.1037/0021-843X.112.3.393 |
0.574 |
|
| Show low-probability matches. |